Pancreatic Cancer Research

Clinical trialNARecruiting

Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer: The SMART Study

NCT04276857↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
NA
Status
Recruiting
Study type
Interventional
Start
1 May 2025
Expected end
31 December 2026
Enrollment
27 participants
Sites
2
Primary outcomes
1 year progression free survival rate of patients with locally advanced pancreatic cancer who are treated with IRE and combination chemotherapy.
Sponsor
Other
Results posted
No
Last update
13 May 2025

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 8